579478-81-2 Usage
Imidazole ring
Heterocyclic compound
The imidazole ring is a five-membered ring with two nitrogen atoms, which contributes to the compound's potential pharmacological and biological activities.
Cyclopropyl group
Structural component
The presence of a cyclopropyl group, a three-carbon ring with one hydrogen atom attached to each carbon, adds to the complexity and uniqueness of the compound.
Potential pharmacological and biological activities
Therapeutic potential
The combination of the imidazole ring and cyclopropyl group may result in the compound having various pharmacological and biological effects, although further research is needed to confirm this.
Medicinal chemistry and drug development
Possible applications
The unique structure and properties of 1H-Imidazole,2-(1a,6-dihydrocycloprop[a]inden-6a(1H)-yl)-4,5-dihydro-(9CI) suggest that it could be used in the development of new medications and therapies.
Treatment of various diseases and conditions
Potential applications
Due to its complex structure, the compound may have potential applications in treating a range of diseases and conditions, although more research is needed to determine its specific uses and effects.
Limited research and analysis
Need for further study
1H-Imidazole,2-(1a,6-dihydrocycloprop[a]inden-6a(1H)-yl)-4,5-dihydro-(9CI) has not been extensively studied, and additional research is required to fully understand its potential uses and effects.
Check Digit Verification of cas no
The CAS Registry Mumber 579478-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,7,9,4,7 and 8 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 579478-81:
(8*5)+(7*7)+(6*9)+(5*4)+(4*7)+(3*8)+(2*8)+(1*1)=232
232 % 10 = 2
So 579478-81-2 is a valid CAS Registry Number.
579478-81-2Relevant articles and documents
Novel tricycloimidazoline derivatives method for production and use thereof as medicaments
-
Page/Page column 6, (2010/02/11)
The invention relates to compounds of general formula (1) in which R1=H, F or OCH3 and may occupy the 2, 3, 4 or 5 position on the aromatic carbocycle, R2=H or CH3, R3=H, CH3, OH or OCH3, R4=H and R3 and R4 together can be a carbonyl group (C=0), the addition salts and optionally the hydrates of additional salts with pharmaceutically-acceptable mineral or organic acids and the isomers and tautomers thereof.
